| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.07 | $1.60 | $0.99 | $0.90 | $-1.55 |
| EPS (Diluted) | $1.91 | $1.52 | $0.94 | $0.86 | $-1.55 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Total Assets | $5.5B | $4.4B | $3.7B | $2.8B | $2.1B |
| Current Assets | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $5.0B | $4.0B | $3.4B | $2.5B | $1.8B |
| Current Liabilities | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.4B | $0.4B | $0.3B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| Investing Cash Flow | $-1.0B | $-0.6B | $-0.9B | $-0.7B | $0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $1.0B | $0.5B | $0.9B | $0.6B | $-0.1B |